Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• Multidrug resistance (MDR) in cancer cells involves reduced intracellular accumulation of various chemotherapeutic agents.
• Structurally unrelated drugs like colchicine, vinblastine, and adriamycin are often effluxed by resistant cells.
• Understanding the molecular mechanisms of MDR is crucial for improving cancer treatment efficacy.

Purpose of the Study:

• To investigate the mechanism behind reduced drug accumulation in multidrug-resistant human KB carcinoma cells.
• To quantify the binding of [3H]vinblastine ([3H]VBL) to membrane vesicles from drug-sensitive and drug-resistant cell lines.
• To explore the characteristics of [3H]VBL binding in resistant cells and its modulation by verapamil.

Main Methods:

• Preparation of membrane vesicles from drug-sensitive (KB-3-1), drug-resistant (KB-C4), and revertant (KB-R1) human KB carcinoma cell lines.
• Measurement of [3H]vinblastine ([3H]VBL) binding to these membrane vesicles.
• Assessment of [3H]dexamethasone binding to rule out non-specific uptake differences.
• Evaluation of the effect of verapamil on [3H]VBL binding.
• Analysis of drug binding characteristics (osmotic sensitivity, temperature dependence, trypsin sensitivity) and inhibition by other drugs and tubulin content.

Main Results:

• Membrane vesicles from multidrug-resistant KB-C4 cells exhibited up to an 8-fold increase in [3H]VBL binding compared to sensitive KB-3-1 or revertant KB-R1 cells.
• No difference in [3H]dexamethasone binding was observed between sensitive and resistant cells.
• The increased [3H]VBL binding in resistant cells was reversed by verapamil, a known modulator of MDR.
• [3H]VBL binding was osmotically insensitive, temperature-dependent, and trypsin-sensitive, and inhibited by vinblastine, vincristine, and daunomycin.
• No significant differences in tubulin content were detected between cell lines.

Conclusions:

• The data demonstrate that membrane vesicles from multidrug-resistant cells bind increased amounts of vinblastine.
• This increased binding suggests a specific mechanism involving the drug-binding site within the cell membrane, potentially related to drug efflux pumps.
• The findings contribute to understanding the molecular basis of vinblastine resistance in cancer cells.